AR002987A1 - Composicion farmaceutica para el tratamiento de infecciones virales ocanceres o tumores, composicion de dosis unitaria que la comprende y uso para dicho tratamiento - Google Patents
Composicion farmaceutica para el tratamiento de infecciones virales ocanceres o tumores, composicion de dosis unitaria que la comprende y uso para dicho tratamientoInfo
- Publication number
- AR002987A1 AR002987A1 ARP960102167A AR10216796A AR002987A1 AR 002987 A1 AR002987 A1 AR 002987A1 AR P960102167 A ARP960102167 A AR P960102167A AR 10216796 A AR10216796 A AR 10216796A AR 002987 A1 AR002987 A1 AR 002987A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- treatment
- viral infections
- tumors
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención trata de una composición que inhibe el crecimiento de cánceres y tumores en los mamíferos, particularmente en los seres humanos yanimales de sangre caliente. La composición además es eficaz para combatir infeccionesvirales . La composición contiene N-clorofenilcarbamato y N-clorofeniltiocarbamato que son herbicidas sistemáticos. La composición también, puede tener N-clorofenilcarbamatos y N-clorofeniltiocarbamatos junto con unagente quimioterapéutico y unpotenciador o pcional. Una composición para tratar infecciones virales en animales y seres humanos, que comprende una cantidadsegura y eficaz de N-clorofenilcarbamatos y N-clorofeniltiocarbamatos y un potenciador.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/420,913 US5629341A (en) | 1995-04-12 | 1995-04-12 | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
Publications (1)
Publication Number | Publication Date |
---|---|
AR002987A1 true AR002987A1 (es) | 1998-05-27 |
Family
ID=23668357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960102167A AR002987A1 (es) | 1995-04-12 | 1996-04-12 | Composicion farmaceutica para el tratamiento de infecciones virales ocanceres o tumores, composicion de dosis unitaria que la comprende y uso para dicho tratamiento |
Country Status (3)
Country | Link |
---|---|
US (1) | US5629341A (es) |
AR (1) | AR002987A1 (es) |
ZA (1) | ZA962878B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6177460B1 (en) | 1995-04-12 | 2001-01-23 | The Procter & Gamble Company | Method of treatment for cancer or viral infections |
US6479526B1 (en) | 1995-04-12 | 2002-11-12 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
US6262093B1 (en) | 1995-04-12 | 2001-07-17 | The Proctor & Gamble Company | Methods of treating cancer with benzimidazoles |
ZA962879B (en) * | 1995-04-12 | 1997-03-17 | Procter & Gamble | A pharmaceutical composition for inhibiting the growth of viruses and cancers |
WO1996032104A1 (en) * | 1995-04-12 | 1996-10-17 | The Procter & Gamble Company | A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers |
US5770616A (en) | 1995-06-07 | 1998-06-23 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers |
US6265427B1 (en) | 1995-06-07 | 2001-07-24 | The Proctor & Gamble Company | Pharmaceutical composition for the method of treating leukemia |
US6686391B2 (en) | 1995-08-04 | 2004-02-03 | University Of Arizona Foundation | N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions |
US5900429A (en) | 1997-01-28 | 1999-05-04 | The Procter & Gamble Company | Method for inhibiting the growth of cancers |
US6506783B1 (en) | 1997-05-16 | 2003-01-14 | The Procter & Gamble Company | Cancer treatments and pharmaceutical compositions therefor |
US6245789B1 (en) | 1998-05-19 | 2001-06-12 | The Procter & Gamble Company | HIV and viral treatment |
US6423734B1 (en) | 1999-08-13 | 2002-07-23 | The Procter & Gamble Company | Method of preventing cancer |
US6608096B1 (en) | 2000-09-26 | 2003-08-19 | University Of Arizona Foundation | Compounds and methods for use thereof in the treatment of cancer or viral infections |
US6380232B1 (en) | 2000-09-26 | 2002-04-30 | The Procter & Gamble Company | Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof |
US6407105B1 (en) | 2000-09-26 | 2002-06-18 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
US6462062B1 (en) * | 2000-09-26 | 2002-10-08 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
AU2002239395A1 (en) * | 2000-11-01 | 2002-06-03 | The Procter And Gamble Company | Hiv treatment with benzimidazoles |
US6515074B2 (en) * | 2001-01-22 | 2003-02-04 | Delphi Technologies, Inc. | Thermoplastic polymer alloy compositions and process for manufacture thereof |
US7022712B2 (en) * | 2002-03-26 | 2006-04-04 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Solubilization of weak bases |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2734911A (en) * | 1956-02-14 | Reaction of chloroaniline and isopropyl | ||
US2695225A (en) * | 1954-05-21 | 1954-11-23 | Columbia Southern Chem Corp | Herbicidal compositions |
US2806051A (en) * | 1955-11-01 | 1957-09-10 | Goodrich Co B F | Method for preparing urethanes by reacting urea, amines and an alcohol |
US3903297A (en) * | 1973-11-01 | 1975-09-02 | Upjohn Co | Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs |
US5114951A (en) * | 1989-04-11 | 1992-05-19 | Burroughs Wellcome Company | Agents for combating multiple drug resistance |
US5254715A (en) * | 1990-11-07 | 1993-10-19 | Warner-Lambert Company | Aminosulfonyl carbamates |
-
1995
- 1995-04-12 US US08/420,913 patent/US5629341A/en not_active Expired - Lifetime
-
1996
- 1996-04-11 ZA ZA962878A patent/ZA962878B/xx unknown
- 1996-04-12 AR ARP960102167A patent/AR002987A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA962878B (en) | 1997-03-17 |
US5629341A (en) | 1997-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR002987A1 (es) | Composicion farmaceutica para el tratamiento de infecciones virales ocanceres o tumores, composicion de dosis unitaria que la comprende y uso para dicho tratamiento | |
AR003120A1 (es) | Composicion farmaceutica para tratar canceres, tumores o infecciones virosicas y composicion de dosificacion unitaria que la comprende. | |
AR003119A1 (es) | Composicion farmaceutica para tratar infecciones virosicas o inhibir el crecimiento de tumores o canceres que comprenden una mezcla de un n- clorofenilcarbamato o un n- clorofeniltiocarbamato y un n- fosfonoglicina y uso de dicha composicion farmaceutica para la manufactura de un medicamento para tratar infecciones virosicas o inhibir el crecimiento de tumores o canceres | |
ES2196026T3 (es) | Uso de ndv en la fabricacion de un medicamento para tratar el cancer. | |
CY1107615T1 (el) | Θεραπευτικοι συνδυασμοι αντιυπερτασικων και αντιαγγειογενετικων παραγοντων | |
DE69430611T2 (de) | Phosphonooxymethyl oder Methylthiomethylether von Taxanderivaten als Antitumormittel | |
TR200002965T2 (tr) | Enfeksiyonların terapötik ve profilaktik tedavisi için organofosforlu terkiplerin kullanımı | |
BR9604973A (pt) | Uma composição farmacêutica contendo carbamatos de n-cloro fenila e tiocarbamatos de n-cloro fenila para inibição de crescimento de vírus e cânceres | |
AR021370A1 (es) | Composiciones farmaceuticas inyectables estabilizadas que contienen agentes anti-neoplasicos taxoides | |
BR0208017A (pt) | Combinação compreendendo combretastatina e agentes anticâncer | |
BR0009524A (pt) | Uso de um composto, e, composição farmacêutica ou veterinaria | |
AR003174A1 (es) | Una composicion farmaceutica que comprende un portador farmaceuticamente aceptable y un agente quimioterapeutico y un triazol, dicha composicion farmaceutica que comprende un potenciador, uso de un agente quimioterapeutico y un 1h-1,2,4-triazol y uso de un potenciador y dicho triazol para tratar cancer, tumor o infecciones virales en mamiferos de sangre caliente | |
ES2056902T3 (es) | Uso de n-(amino terciario)benzamida sustituidas. | |
AR018162A1 (es) | Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica | |
PT671174E (pt) | Formulacao para o aumento de peso do gado que compreende um ionoforo e selenio | |
ES2071995T3 (es) | Composicion para la activacion de macrofagia. | |
MX9405371A (es) | Derivado de naftilo. | |
MX9707808A (es) | Una composicion farmaceutica que contiene n-clorofenilcarbamatos y n-clorofiniltiocarbamatos para inhibir el crecimiento de virus y canceres. | |
ES2147796T3 (es) | Composicion para el tratamiento o la prevencion del herpes. | |
AR008154A1 (es) | Acido (s)-7-[(4,4'-bipiperidin-1-il)carbonil]-2,3,4,5-tetrahidro-4-metil- -3-oxo-1h-1,4-benzodiazepina-2-acetico, como hidrocloruro del mismo, unacomposicion farmaceutica que lo comprende, el uso del mismo y un procedimiento para su preparacion. | |
DE69426986T2 (de) | Behandlung von laminitis | |
AR013498A1 (es) | Uso de ifn-alfa y amantadine para el tratamiento de hepatitis c cronica uso de ifn-alfa | |
AR230923A1 (es) | Procedimiento de fabricacion de composiciones pesticidas para el tratamiento de madera,dichas composiciones y procedimiento para la proteccion de materiales de madera | |
ES2131468B1 (es) | Uso de la melatonina en el tratamiento de las enfermedades neurodegenerativas. | |
AR003471A1 (es) | Metodo de tratamiento de las convulsiones en un paciente que lo necesite con compuesto n-(pirrol-1-il)piridinaminas no substituidos y substituidas,composicion farmaceutica y uso de dichos compuestos en la preparacion de una composicion farmaceutica para el tratamiento de las convulsiones. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |